[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Viral Molecular Diagnostics - Global Market Outlook (2015-2022)

February 2016 | 138 pages | ID: V3E25D29304EN
Stratistics Market Research Consulting

US$ 4,150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to Stratistics MRC, the Global Viral Molecular Diagnostics Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Growing incidence of viral diseases, rising aged population, technological advances in molecular diagnostics, increasing awareness about viral diseases and rising government initiatives in several regions are the key factors fueling the market growth. On the other hand, absence of skilled professionals and huge cost of molecular diagnostics are some of the key factors limiting the viral molecular diagnostics market growth.

North America is the major market for the viral molecular diagnostics followed by the Western Europe owing to growing number of key players within this market. Superior infrastructure and top awareness levels about various viral diseases among the people in these regions are the key factors attributed for their highest share. Asia-Pacific is the fastest growing market for various viral molecular diagnostic tests, owing to growing incidence of viral infections in this market.

Some of the key players in the global viral molecular diagnostics market include Meridian Bioscience Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Corporation, BioMerieux SA, Auto Genomics Inc., Qiagen NV, Affymetrix Inc., Illumina Inc., Gen-Probe Inc., Roche Molecular Diagnostics, Siemens, Cepheid and Beckman Coulter.

Applications Covered:
  • Respiratory Syncytial Virus
  • Hepatitis
  • AIDS
  • Influenza
  • Others
Technologies Covered:
  • Real time PCR (RT-PCR)
  • Polymerase chain reaction (PCR)
  • Nucleic Acid Sequence Based Amplification
  • Other Molecular Diagnostic methods
    • Isothermal nucleic acid amplification technology (INAAT)
    • Microarrays
    • In situ hybridization
End User’s Covered:
  • Academic Institutions
  • Hospitals
  • Ambulatory clinics
  • Diagnostic Laboratories
Products Covered:
  • Reagents
  • Instrument
  • Others
Regions Covered:
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • Rest of the World
    • Middle East
    • Brazil
    • Argentina
    • South Africa
    • Egypt
What our report offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Product Analysis
3.10 Emerging markets

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL VIRAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION

5.1 Introduction
5.2 Respiratory Syncytial Virus
5.3 Hepatitis
5.4 AIDS
5.5 Influenza
5.6 Other Applications

6 GLOBAL VIRAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

6.1 Introduction
6.2 Real time PCR (RT-PCR)
6.3 Polymerase chain reaction (PCR)
6.4 Nucleic Acid Sequence Based Amplification
6.5 Other Molecular Diagnostic methods
  6.5.1 Isothermal nucleic acid amplification technology (INAAT)
  6.5.2 Microarrays
  6.5.3 In situ hybridization

7 GLOBAL VIRAL MOLECULAR DIAGNOSTICS MARKET, BY END USER

7.1 Introduction
7.2 Academic Institutions
7.3 Hospitals
7.4 Ambulatory clinics
7.5 Diagnostic Laboratories

8 GLOBAL VIRAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT

8.1 Introduction
8.2 Reagents
8.3 Instrument
8.4 Other Products

9 GLOBAL VIRAL MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY

9.1 North America
  9.1.1 US
  9.1.2 Canada
  9.1.3 Mexico
9.2 Europe
  9.2.1 Germany
  9.2.2 France
  9.2.3 Italy
  9.2.4 UK
  9.2.5 Spain
  9.2.6 Rest of Europe
9.3 Asia Pacific
  9.3.1 Japan
  9.3.2 China
  9.3.3 India
  9.3.4 Australia
  9.3.5 New Zealand
  9.3.6 Rest of Asia Pacific
9.4 Rest of the World
  9.4.1 Middle East
  9.4.2 Brazil
  9.4.3 Argentina
  9.4.4 South Africa
  9.4.5 Egypt

10 KEY DEVELOPMENTS

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 COMPANY PROFILING

11.1 Meridian Bioscience Inc.
11.2 Becton Dickinson and Company
11.3 F. Hoffmann-La Roche Ltd.
11.4 Abbott Laboratories Inc.
11.5 Thermo Fisher Scientific Corporation
11.6 BioMerieux SA
11.7 Auto Genomics Inc.
11.8 Qiagen NV
11.9 Affymetrix Inc.
11.10 Illumina Inc.
11.11 Gen-Probe Inc.
11.12 Roche Molecular Diagnostics
11.13 Siemens
11.14 Cepheid
11.15 Beckman Coulter

LIST OF TABLES

Global Viral Molecular Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Global Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
North America Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Europe Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Asia Pacific Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Respiratory Syncytial Virus (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Hepatitis (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By AIDS (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Influenza (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Real time PCR (RT-PCR) (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Polymerase chain reaction (PCR) (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Nucleic Acid Sequence Based Amplification (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Other Molecular Diagnostic methods (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Academic Institutions (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Ambulatory clinics (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Diagnostic Laboratories (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Product Type (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Reagents (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Instrument (2013-2022) ($MN)
Rest of the World Viral Molecular Diagnostics Market Outlook, By Other Products (2013-2022) ($MN)


More Publications